Michael Kelly
Amministratore Delegato presso NERVGEN PHARMA CORP.
Patrimonio netto: 889 226 $ in data 30/04/2024
Posizioni attive di Michael Kelly
Società | Posizione | Inizio | Fine |
---|---|---|---|
ARS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/05/2019 | - |
Independent Dir/Board Member | 01/05/2019 | - | |
NERVGEN PHARMA CORP. | Direttore/Membro del Consiglio | 10/04/2023 | - |
Amministratore Delegato | 10/04/2023 | - | |
Presidente | 10/04/2023 | - | |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ARS Pharmaceuticals, Inc. develops epinephrine nasal sprays for treatment of severe allergic reactions to food, medication, and insect bites. The company was founded by Richard E. Lowenthal, Sarina Tanimoto and Robert Bell and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | 01/05/2019 | - |
Storia della carriera di Michael Kelly
Precedenti posizioni note di Michael Kelly
Società | Posizione | Inizio | Fine |
---|---|---|---|
Emergent Devices, Inc.
Emergent Devices, Inc. Pharmaceuticals: MajorHealth Technology Part of Emergent BioSolutions, Inc., Emergent Devices, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Plymouth Meeting, PA. | Direttore operativo | 01/03/2016 | 01/06/2019 |
Covis Pharmaceuticals, Inc.
Covis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Covis Pharmaceuticals, Inc. specializes and distributes pharmaceutical products. It is a specialty pharmaceutical distributor dedicated to improving the lives of people with life-threatening conditions and chronic illnesses. The company was founded on November 2, 2011 and is headquartered in Chesterbrook, PA. | Direttore/Membro del Consiglio | 01/12/2013 | 01/03/2016 |
Amministratore Delegato | 01/12/2013 | 01/03/2016 | |
Presidente | 01/12/2013 | 01/03/2016 | |
Azur Pharma Ltd.
Azur Pharma Ltd. Pharmaceuticals: MajorHealth Technology Azur Pharma Ltd. manufactures pharmaceutical products. It offers branded generic prescription drugs, antibiotics and medicines in multiple therapeutic areas. The company was founded in May, 2005 and is headquartered in Dublin, IE | Corporate Officer/Principal | - | 27/01/2012 |
Jazz Pharmaceuticals Commercial Corp.
Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals Commercial Corp. provides pharmaceutical services. It engages in identifying, developing, and commercializing products in the areas of CNS, women's health, and urology. The company was founded in 2005 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 07/12/2010 | 01/01/2012 |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Direttore operativo | - | 03/10/2005 |
Viropharma, Inc. | Vendite & Marketing | - | - |
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Michael Kelly
Rider University | Masters Business Admin |
The College of New Jersey | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 10 |
Irlanda | 3 |
Canada | 2 |
Posizioni
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Sales & Marketing | 2 |
Settori
Health Technology | 10 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
JAZZ PHARMACEUTICALS PLC | Health Technology |
ARS PHARMACEUTICALS, INC. | Health Technology |
NERVGEN PHARMA CORP. | Health Technology |
Aziende private | 7 |
---|---|
Jazz Pharmaceuticals Commercial Corp.
Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals Commercial Corp. provides pharmaceutical services. It engages in identifying, developing, and commercializing products in the areas of CNS, women's health, and urology. The company was founded in 2005 and is headquartered in Philadelphia, PA. | Health Technology |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ARS Pharmaceuticals, Inc. develops epinephrine nasal sprays for treatment of severe allergic reactions to food, medication, and insect bites. The company was founded by Richard E. Lowenthal, Sarina Tanimoto and Robert Bell and is headquartered in San Diego, CA. | Health Technology |
Covis Pharmaceuticals, Inc.
Covis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Covis Pharmaceuticals, Inc. specializes and distributes pharmaceutical products. It is a specialty pharmaceutical distributor dedicated to improving the lives of people with life-threatening conditions and chronic illnesses. The company was founded on November 2, 2011 and is headquartered in Chesterbrook, PA. | Health Technology |
Emergent Devices, Inc.
Emergent Devices, Inc. Pharmaceuticals: MajorHealth Technology Part of Emergent BioSolutions, Inc., Emergent Devices, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Plymouth Meeting, PA. | Health Technology |
Azur Pharma Ltd.
Azur Pharma Ltd. Pharmaceuticals: MajorHealth Technology Azur Pharma Ltd. manufactures pharmaceutical products. It offers branded generic prescription drugs, antibiotics and medicines in multiple therapeutic areas. The company was founded in May, 2005 and is headquartered in Dublin, IE | Health Technology |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
Viropharma, Inc. |
- Borsa valori
- Insiders
- Michael Kelly
- Esperienza